Recombinant Feline Herpesvirus-1 (FHV-1) Expressing Granulocyte Colony-Stimulating Factor (G-CSF) Exhibits Enhanced Protective Efficacy in Felines

Mengfang Yang,Yuzhou Jiao,Yuanyuan Yan,Zhen Fu,Lisha Li,Zirui Liu,Lingying Fang,Xiaoshuai Hu,Benyuan Wu,Yuejun Shi,Mengxia Li,Zhou Shen,Guiqing Peng
DOI: https://doi.org/10.1016/j.virol.2024.110282
IF: 3.513
2024-01-01
Virology
Abstract:Vaccine efficacy relies not only on antigens but also on immunomodulatory agents/adjuvants that are often used to stimulate the immune system and enhance the immune response. However, current immunomodulatory agents are used to increase the immune response induced by viral or bacterial inactivated vaccine antigens, bacterial toxoids or polysaccharides but not attenuated live viruses. Based on the immunomodulatory functions of G-CSF and the characteristics of feline herpesvirus-1 (FHV-1) as an expression vector, a recombinant virus expressing feline G-CSF (WH2020-ΔTK/gI/gE-G-CSF) was constructed. The growth dynamics of WH2020-ΔTK/gI/gE-G-CSF were similar to those of WH2020-ΔTK/gI/gE. Compared with kittens vaccinated with WH2020 Δ TK/gI/gE, felines inoculated with WH2020 ΔTK/gI/gE-G-CSF produced more neutralizing antibodies and neutrophils, further alleviating clinical symptoms after FHV-1 infection. Taken together, our results revealed the potential of G-CSF as an ideal immune potentiator that can augment immune responses to FHV-1 and even other attenuated live vaccines.
What problem does this paper attempt to address?